Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger

Starting soon · Phase 2

Conditions studied: Infertility (IVF Patients)

In brief

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \[a single bolos of HCG combined with two successive doses of a GnRH agonist \] with HCG \[a single bolos administered 36 hours before oocyte retrieval \] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

Key facts

Study ID

NCT07569302

Run by

Bedaya Hospital

People needed

196

Starts

2026-06-01

Expected to finish

2028-04-01

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• GnRH antagonist IVF cycle
• Normo-responders to induction of ovulation

You may not qualify if…

• Hypogonadotrophic hypogonadism
• Endometriosis
• History of recurrent abortion

Where it is running

• Bedaya Hospital — Giza, Giza Governorate, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.